Table 1.
Donor | Recipient | Recipient Treatment | Harvest Time (Days) | n | ARa | CRb |
---|---|---|---|---|---|---|
B6 RAG−/− | B6 RAG−/− | None | 72 – 75 | 6 | 0 | 0 |
BALB/c RAG−/− | B6 RAG−/− | 1×107 B6 T cells i.v.c | 11–14d | 3 | 3 | 0 |
B10.BR | B6 RAG−/− | None | 79 – 82 | 7 | 0 | 0 |
B6 RAG−/− | BALB/c RAG−/− | CFAe | 77 – 85 | 7 | 0 | 0 |
B6 RAG−/− | BALB/c RAG−/− | Poly I:Cf | 60 – 75 | 4 | 0 | 0 |
B6 RAG−/− | BALB/c RAG−/− | CpGf | 70 – 75 | 4 | 0 | 0 |
B6 RAG−/− | BALB/c RAG−/− | B-1 reconstitution | 50 (n = 2) 90 (n = 1) |
3 | 0 | 0 |
B6 RAG−/− | BALB/c RAG−/− | Alloimmunizationg | 49 – 57 | |||
B6 RAG−/− | BALB/c RAG−/− | Alloimmunization + CFA | 48 – 57 | 7 | 0 | 0 |
AR = Acute Rejection
. CR = Chronic Rejection.
T cells were injected 50 days after transplantation.
Hearts were harvested upon cessation of palpable heart beat (median graft survival = 11.5 days after T cell injection) and rejection was confirmed histologically.
CFA (200 μl) was administered i.p. 7 days prior to transplantation.
Poly I:C (100 μg) and CpG-1826 (25 μg) were administered i.v. on the day of transplantation and once or twice weekly thereafter.
Alloimmunization was performed by injecting 2 × 107 B6 RAG−/− splenocytes i.p. 7 days prior to transplantation.